New preclinical guidelines on drug effects on ventricular repolarization: safety pharmacology comes of age.
Autor: | Kinter LB; Safety Assessment U.S., Development, AstraZeneca Pharmaceuticals, Wilmington, DE 19850-5437, USA. lewis.kinter@astrazeneca.com, Siegl PK, Bass AS |
---|---|
Jazyk: | angličtina |
Zdroj: | Journal of pharmacological and toxicological methods [J Pharmacol Toxicol Methods] 2004 May-Jun; Vol. 49 (3), pp. 153-8. |
DOI: | 10.1016/j.vascn.2004.03.007 |
Databáze: | MEDLINE |
Externí odkaz: |